๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B

โœ Scribed by M.J. ter Borg; B.E. Hansen; G. Bigot; B.L. Haagmans; H.L.A. Janssen


Book ID
116631362
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
261 KB
Volume
42
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Patterns of viral decline during PEG-int
โœ Martijn J. ter Borg; Monika van Zonneveld; Stefan Zeuzem; Hakan Senturk; Ulus S. ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 423 KB ๐Ÿ‘ 2 views

In chronic hepatitis B, it is difficult to predict an early therapeutic response. We investigated the viral decline during therapy with pegylated interferon alpha-2b (PEG-IFN) with or without lamivudine in 266 HBeAg-positive chronic hepatitis B patients. In patients treated with PEG-IFN and lamivudi

HBeAg and hepatitis B virus DNA as outco
โœ Michael W. Fried; Teerha Piratvisuth; George K. K. Lau; Patrick Marcellin; Wan-C ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 414 KB ๐Ÿ‘ 2 views

The aims of this study were to evaluate the usefulness of quantitative hepatitis B e antigen (HBeAg) values for predicting HBeAg seroconversion in patients treated with peginterferon alfa-2a and to assess the dynamic changes in quantitative HBeAg during therapy, compared with conventional measures o